Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Wittwer

Showing results (41-50 of 59) with videos related to

Pageof 6
Sort By:
Nucleic Acids Research|June 10, 2022
Considerations and recommendations for assessment of plasma protein binding and drug-drug interactions for siRNA therapeuticsSara C Humphreys, John A Davis, Sajida Iqbal, et al.
Cell Communication and Signaling : CCS|October 11, 2025
Relevance of a peripheral site of action outside the brain-blood barrier for the beneficial effects of CB<sub>2</sub> receptor activation in experimental ALS in male miceMarta Gómez-Almería, Claudia Gonzalo-Consuegra, Carmen Rodríguez-Cueto, et al.
Clinical Pharmacology and Therapeutics|May 16, 2018
ITC Commentary on Metformin Clinical Drug-Drug Interaction Study Design That Enables an Efficacy- and Safety-Based Dose Adjustment DecisionMaciej J Zamek-Gliszczynski, Xiaoyan Chu, Jack A Cook, et al.
Clinical Pharmacokinetics|November 25, 2015
The Effect of Famotidine, a MATE1-Selective Inhibitor, on the Pharmacokinetics and Pharmacodynamics of MetforminJennifer E Hibma, Arik A Zur, Richard A Castro, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 2, 2024
Identification of (<i>R</i>)-[<sup>18</sup>F]YH134 for Monoacylglycerol Lipase Neuroimaging and Exploration of Its Use for Central Nervous System and Peripheral Drug DevelopmentYingfang He, Stefanie D Krämer, Uwe Grether, et al.
Clinical Pharmacology and Therapeutics|August 10, 2018
Transporters in Drug Development: 2018 ITC Recommendations for Transporters of Emerging Clinical ImportanceMaciej J Zamek-Gliszczynski, Mitchell E Taub, Paresh P Chothe, et al.
Nuclear Medicine and Biology|March 6, 2022
Discovery, synthesis and evaluation of novel reversible monoacylglycerol lipase radioligands bearing a morpholine-3-one scaffoldYingfang He, Luca C Gobbi, Adrienne Müller Herde, et al.
Pharmacological Research|November 8, 2025
Kinetic multiplex assay to assess biased signaling of clinical GPCR agonistsJara Bouma, Elisa J M de Koning, Cas van der Horst, et al.
Nature Genetics|May 1, 1996
A gene (RPGR) with homology to the RCC1 guanine nucleotide exchange factor is mutated in X-linked retinitis pigmentosa (RP3)A Meindl, K Dry, K Herrmann, et al.
ACS Chemical Neuroscience|September 18, 2025
Tritium-Labeled Compounds in PET Tracer Discovery? A Case Study from Roche's Internal Monoacylglycerol Lipase ProgramMartin R Edelmann, Luca C Gobbi, Svenja Schmalzbauer, et al.
Pageof 6

Showing results (41-50 of 59) with videos related to

Sort By:
Pageof 6
Nucleic Acids Research|June 10, 2022
Considerations and recommendations for assessment of plasma protein binding and drug-drug interactions for siRNA therapeuticsSara C Humphreys, John A Davis, Sajida Iqbal, et al.
Cell Communication and Signaling : CCS|October 11, 2025
Relevance of a peripheral site of action outside the brain-blood barrier for the beneficial effects of CB<sub>2</sub> receptor activation in experimental ALS in male miceMarta Gómez-Almería, Claudia Gonzalo-Consuegra, Carmen Rodríguez-Cueto, et al.
Clinical Pharmacology and Therapeutics|May 16, 2018
ITC Commentary on Metformin Clinical Drug-Drug Interaction Study Design That Enables an Efficacy- and Safety-Based Dose Adjustment DecisionMaciej J Zamek-Gliszczynski, Xiaoyan Chu, Jack A Cook, et al.
Clinical Pharmacokinetics|November 25, 2015
The Effect of Famotidine, a MATE1-Selective Inhibitor, on the Pharmacokinetics and Pharmacodynamics of MetforminJennifer E Hibma, Arik A Zur, Richard A Castro, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 2, 2024
Identification of (<i>R</i>)-[<sup>18</sup>F]YH134 for Monoacylglycerol Lipase Neuroimaging and Exploration of Its Use for Central Nervous System and Peripheral Drug DevelopmentYingfang He, Stefanie D Krämer, Uwe Grether, et al.
Clinical Pharmacology and Therapeutics|August 10, 2018
Transporters in Drug Development: 2018 ITC Recommendations for Transporters of Emerging Clinical ImportanceMaciej J Zamek-Gliszczynski, Mitchell E Taub, Paresh P Chothe, et al.
Nuclear Medicine and Biology|March 6, 2022
Discovery, synthesis and evaluation of novel reversible monoacylglycerol lipase radioligands bearing a morpholine-3-one scaffoldYingfang He, Luca C Gobbi, Adrienne Müller Herde, et al.
Pharmacological Research|November 8, 2025
Kinetic multiplex assay to assess biased signaling of clinical GPCR agonistsJara Bouma, Elisa J M de Koning, Cas van der Horst, et al.
Nature Genetics|May 1, 1996
A gene (RPGR) with homology to the RCC1 guanine nucleotide exchange factor is mutated in X-linked retinitis pigmentosa (RP3)A Meindl, K Dry, K Herrmann, et al.
ACS Chemical Neuroscience|September 18, 2025
Tritium-Labeled Compounds in PET Tracer Discovery? A Case Study from Roche's Internal Monoacylglycerol Lipase ProgramMartin R Edelmann, Luca C Gobbi, Svenja Schmalzbauer, et al.
Pageof 6